同基因豚鼠的肿瘤移植排斥反应：两步机制的证据。 - Suppr

Suppr

超能文献

Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.

作者信息

Zbar B, Wepsic H T, Borsos T, Rapp H J

出版信息

J Natl Cancer Inst. 1970 Feb;44(2):473-81.

PMID:11515089

Abstract

摘要

相似文献

Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.

J Natl Cancer Inst. 1970 Feb;44(2):473-81.

Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

J Natl Cancer Inst. 1979 Jun;62(6):1459-72.

Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophils.

J Natl Cancer Inst. 1970 Mar;44(3):701-17.

Tumour rejection in immunized guinea-pigs.

Br J Exp Pathol. 1983 Oct;64(5):542-7.

Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.

Cancer Res. 1980 Sep;40(9):3211-3.

Alteration of skin in gross leukemia. I. Syngeneic skin-graft rejection and tumor development.

J Natl Cancer Inst. 1970 Feb;44(2):319-28.

Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection.

Circulation. 2006 Jul 25;114(4):318-27. doi: 10.1161/CIRCULATIONAHA.105.549311. Epub 2006 Jul 10.

Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.

J Heart Lung Transplant. 2008 Apr;27(4):450-6. doi: 10.1016/j.healun.2008.01.015.

A study of the relationship between the graft length, site, and rejection in small bowel transplantation.

Transplant Proc. 2004 Oct;36(8):2452. doi: 10.1016/j.transproceed.2004.07.010.

Intragraft heat shock protein-60 expression after small bowel transplantation in the mouse.

Transplant Proc. 2004 Mar;36(2):350-2. doi: 10.1016/j.transproceed.2003.12.022.

引用本文的文献

The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

Cell Mol Immunol. 2018 Apr;15(4):335-345. doi: 10.1038/cmi.2017.135. Epub 2018 Jan 29.

Immunostimulation. Clinical and experimental perspectives.

Klin Wochenschr. 1984 Mar 15;62(6):254-64. doi: 10.1007/BF01721886.

Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages.

J Exp Med. 1973 Sep 1;138(3):625-44. doi: 10.1084/jem.138.3.625.

Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates.

J Exp Med. 1973 Mar 1;137(3):751-75. doi: 10.1084/jem.137.3.751.

Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells.

J Exp Med. 1973 Sep 1;138(3):672-85. doi: 10.1084/jem.138.3.672.

Suppression of growth of Ehrlich ascites tumor cells in mice by trehalose-6,6'-dimycolate (cord factor) and BCG.

Infect Immun. 1974 Jun;9(6):977-84. doi: 10.1128/iai.9.6.977-984.1974.

Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures.

Cancer Immunol Immunother. 1986;22(3):204-10. doi: 10.1007/BF00200034.

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. II. Lyt-1+2- T cells have potential to reject antigenically irrelevant (bystander) tumor cells on activation with the specific target tumor cells.

Cancer Immunol Immunother. 1987;24(1):8-12. doi: 10.1007/BF00199826.

Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants.

J Exp Med. 1989 Apr 1;169(4):1449-59. doi: 10.1084/jem.169.4.1449.

Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye.

Cancer Immunol Immunother. 1990;30(6):323-30. doi: 10.1007/BF01786881.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验